| SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Aβ‐Degrading Enzymes in Alzheimer's Disease JS Miners, S Baig, J Palmer, LE Palmer, PG Kehoe, S Love Brain pathology 18 (2), 240-252, 2008 | 474 | 2008 |
| Aβ-degrading enzymes: potential for treatment of Alzheimer disease JS Miners, N Barua, PG Kehoe, S Gill, S Love Journal of Neuropathology & Experimental Neurology 70 (11), 944-959, 2011 | 319 | 2011 |
| Cerebrovascular disease in ageing and Alzheimer’s disease S Love, JS Miners Acta neuropathologica 131, 645-658, 2016 | 309 | 2016 |
| Cognitive impact of COVID-19: looking beyond the short term S Miners, PG Kehoe, S Love Alzheimer's research & therapy 12 (1), 170, 2020 | 258 | 2020 |
| Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology PG Kehoe, S Wong, N Al Mulhim, LE Palmer, JS Miners Alzheimer's research & therapy 8, 1-10, 2016 | 207 | 2016 |
| Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer’s disease and vascular dementia T Thomas, S Miners, S Love Brain 138 (4), 1059-1069, 2015 | 201 | 2015 |
| Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy JS Miners, Z Van Helmond, K Chalmers, G Wilcock, S Love, PG Kehoe Journal of Neuropathology & Experimental Neurology 65 (10), 1012-1021, 2006 | 190 | 2006 |
| Angiotensins in Alzheimer's disease–friend or foe? PG Kehoe, S Miners, S Love Trends in neurosciences 32 (12), 619-628, 2009 | 189 | 2009 |
| Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes S Miners, E Ashby, S Baig, R Harrison, H Tayler, E Speedy, JA Prince, ... American journal of translational research 1 (2), 163, 2009 | 189 | 2009 |
| Angiotensin‐converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE‐1 to cerebral amyloid angiopathy JS Miners, E Ashby, Z Van Helmond, KA Chalmers, LE Palmer, S Love, ... Neuropathology and applied neurobiology 34 (2), 181-193, 2008 | 185 | 2008 |
| Differing associations between Aβ accumulation, hypoperfusion, blood–brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in … JS Miners, I Schulz, S Love Journal of Cerebral Blood Flow & Metabolism 38 (1), 103-115, 2018 | 179 | 2018 |
| Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity JS Miners, S Baig, H Tayler, PG Kehoe, S Love Journal of Neuropathology & Experimental Neurology 68 (8), 902-914, 2009 | 151 | 2009 |
| ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease CE Evans, JS Miners, G Piva, CL Willis, DM Heard, EJ Kidd, MA Good, ... Acta Neuropathologica 139 (3), 485-502, 2020 | 123 | 2020 |
| Changes with age in the activities of β‐secretase and the Aβ‐degrading enzymes neprilysin, insulin‐degrading enzyme and angiotensin‐converting enzyme JS Miners, Z Van Helmond, PG Kehoe, S Love Brain Pathology 20 (4), 794-802, 2010 | 112 | 2010 |
| Pathophysiology of Hypoperfusion of the Precuneus in Early A lzheimer's Disease JS Miners, JC Palmer, S Love Brain Pathology 26 (4), 533-541, 2016 | 105 | 2016 |
| Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy S Love, S Miners, J Palmer, K Chalmers, P Kehoe Front Biosci 14, 4778-4792, 2009 | 99 | 2009 |
| CSF evidence of pericyte damage in Alzheimer’s disease is associated with markers of blood-brain barrier dysfunction and disease pathology JS Miners, PG Kehoe, S Love, H Zetterberg, K Blennow Alzheimer's research & therapy 11, 1-6, 2019 | 98 | 2019 |
| Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson’s disease M Swirski, JS Miners, R de Silva, T Lashley, H Ling, J Holton, T Revesz, ... Alzheimer's research & therapy 6, 1-17, 2014 | 93 | 2014 |
| Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors IG Goodfellow, DJ Evans, AM Blom, D Kerrigan, JS Miners, BP Morgan, ... Journal of virology 79 (18), 12016-12024, 2005 | 93 | 2005 |
| BIN1 is decreased in sporadic but not familial Alzheimer’s disease or in aging EBC Glennon, IJ Whitehouse, JS Miners, PG Kehoe, S Love, KAB Kellett, ... PloS one 8 (10), e78806, 2013 | 86 | 2013 |
